Interview with Saul Breitman, President, Laboratórios Bernabó
Laboratorios Bernabó es una de las empresas farmacéuticas más distinguidos de toda la historia de la Argentina, con más de 70 años en el mercado. ¿Cómo ha cambiado la visión…
Address: Terrada 2346/48 (C1416ARZ), Buenos Aires,Argentina
Tel: +54 11 4501 3213
Web: http://www.laboratoriosbernabo.com/index.php?lang=en
Laboratórios Bernabó has a unique history, where a man with nothing transformed a business into a key player of the Argentine pharma industry. Ranked within the top 20 pharma companies in Argentina, it is probably one of the best known pharmaceutical brands in the country. Laboratorios Bernabo is mainly known for its activities in dentistry, although it has expanded its business portfolio over the years to cover areas such as gastroenterology, cardiology and rheumatology.
Analgesics, Dentistry, Phlebology, Rheumatology, Urology
Laboratorios Bernabó es una de las empresas farmacéuticas más distinguidos de toda la historia de la Argentina, con más de 70 años en el mercado. ¿Cómo ha cambiado la visión…
PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times LatAm Healthcare & Life Sciences Summit in September 2015. He emphasizes the criticality of…
The national coordinator of Plan Nacer and Plan Sumar – two social security programs to improve access to healthcare in Argentina – discusses universal coverage as a constitutional right, and the…
A senior director for Icon plc discusses Argentina’s strengths and weaknesses as a venue for clinical trials, the role the market plays in a global clinical trial strategy, and Icon’s…
Dr. Wanda Dobrzanski discusses Argentina’s potential and attractiveness as a clinical research environment and the biggest challenges facing local and global CROs in Argentina. How has political and popular…
Gador’s first general director from outside of the family discusses his mission, Gador’s key to success, and his method for successfully leading a company in Argentina’s unpredictable and volatile market.…
The founder of Eriochem discusses his firm’s ambitious technology based on a competitive IP strategy and its exciting research on a radically new oncology platform. Today, Eriochem is a vertically…
The general manager of IMS Health Argentina – South Cone weighs in on why his organization plays a crucial role in the pharma industry in Argentina. How does the Argentinean…
Dr. Valverde, a respected authority on pharmacovigilance from the University of Mamonides, discusses the emerging pharmaceutical trade relationship between China and Argentina in the context of the dynamic Argentinian industry.…
Laboratorios Elea’s General Manager tells the story of the laboratories outstanding growth over the previous five years, the his firms upcoming launch of the first Argentinian developed biosimilar product. To…
The founder of Bomi Group’s affiliate in Argentina discusses the accomplishments of his firm thus far, and the challenges they have faced while trying to enter the very consolidated Argentinian…
Aegerion’s representative in Argentina discusses her efforts to raise awareness of Homozygous Familial Hypercholesteremia (HoFH), the rare disease targeted by her company’s ultra-orphan drug, and the remaining challenges of diagnosing…
Daniel Varde, Deloitte’s top consultant for the healthcare and life sciences sector in Latin America, discusses the interaction of global, Latin American, and Argentinian healthcare trends, and strategic techniques for…
See our Cookie Privacy Policy Here